Revenue
2010
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
United Health Products, Inc. (UEEC)
Price$0.05175Cached quote
Net income
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2019
2020
2021
2022
2023
Total cash / debt
CashTotal debt
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $37,500 | $59 | $643 | $4,927 | $34,876 | $183,174 | $242,007 | $53,266 | $162,677 | $3,060 | — | — | $69,071 |
| Gross profit | — | — | $0 | $18,856 | $34 | $448 | $3,611 | $12,606 | $82,185 | $124,076 | $25,754 | $79,714 | $3,060 | — | — | $12,624 |
| Gross margin | — | — | — | 50.28% | 57.63% | 69.67% | 73.29% | 36.15% | 44.87% | 51.27% | 48.35% | 49.00% | 100.00% | — | — | 18.28% |
| Research & development | $269,867 | $355,936 | $598,810 | $624,564 | $237,458 | $245,218 | $666,388 | $76,951 | $19,936 | — | — | — | — | — | — | — |
| Operating expenses | $2.3M | $2.0M | $2.4M | $2.8M | $29.8M | $14.8M | $6.1M | $1.9M | $1.0M | $641,551 | $2.6M | $2.2M | $1.3M | $207,018 | $1.3M | $2.7M |
| Operating income | −$2.3M | −$2.0M | −$2.4M | −$2.8M | −$29.8M | −$14.8M | −$6.1M | −$1.9M | −$928,418 | −$517,475 | −$2.6M | −$2.1M | −$1.3M | −$207,018 | −$1.3M | −$2.6M |
| Operating margin | — | — | — | −7,472.10% | −50,509,550.85% | −2,309,276.98% | −123,688.09% | −5,439.20% | −506.85% | −213.83% | −4,848.71% | −1,286.10% | −43,029.64% | — | — | −3,814.15% |
| EBITDA | −$2.3M | −$2.0M | −$2.4M | −$2.8M | −$29.8M | — | — | — | — | — | — | −$2.0M | −$1.2M | — | — | — |
| EBITDA margin | — | — | — | −7,461.30% | −50,502,686.44% | — | — | — | — | — | — | −1,255.36% | −39,761.67% | — | — | — |
| Net income | −$2.7M | −$2.0M | −$2.6M | −$1.7M | −$30.5M | −$15.7M | −$6.6M | −$5.4M | −$1.5M | −$535,735 | −$2.6M | −$2.1M | −$1.1M | −$281,413 | −$1.6M | −$2.9M |
| Net profit margin | — | — | — | −4,500.00% | −51,778,276.27% | −2,443,452.57% | −134,002.33% | −15,490.22% | −800.76% | −221.37% | −4,865.88% | −1,318.15% | −36,809.35% | — | — | −4,192.21% |
| Basic EPSper basic share | -$0.01 | -$0.01 | -$0.01 | -$0.01 | — | -$0.09 | -$0.04 | -$0.04 | -$0.01 | $0.00 | -$0.02 | -$0.02 | -$0.01 | $0.00 | -$0.02 | -$0.06 |
| Diluted EPSper diluted share | -$0.01 | -$0.01 | -$0.01 | -$0.01 | — | -$0.09 | -$0.04 | -$0.03 | -$0.01 | — | — | -$0.02 | -$0.01 | $0.00 | -$0.02 | -$0.06 |
Owners
Reported shareholders
≈0.42%of listed shares
Thom Brian David1.1M shares · Apr 8, 2025
View holders
| Holder | % owned |
|---|---|
Thom Brian David | ≈0.42%1.1M shares |
SlateStone Wealth, LLC | 0.06%161.91K shares |
Percentages use 261.59M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 8, 2025Form 4 | Thom Brian DavidChief Executive Officer | BuyCommon Shares | 32.0K | $0.24 | $7.7K | 1.10M |
| Mar 31, 2025Form 4 | Thom Brian DavidChief Executive Officer | BuyCommon Shares | 18.0K | $0.26 | $4.7K | 1.07M |